Cargando…
Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298061/ https://www.ncbi.nlm.nih.gov/pubmed/34597438 http://dx.doi.org/10.1111/bjd.20774 |
| _version_ | 1784750617270419456 |
|---|---|
| author | Leus, A.J.G. Horváth, B. Terra, J.B. Diercks, G.F.H. Plaat, B.E.C. Oosting, S.F. Rácz, E. |
| author_facet | Leus, A.J.G. Horváth, B. Terra, J.B. Diercks, G.F.H. Plaat, B.E.C. Oosting, S.F. Rácz, E. |
| author_sort | Leus, A.J.G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9298061 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92980612022-07-21 Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck Leus, A.J.G. Horváth, B. Terra, J.B. Diercks, G.F.H. Plaat, B.E.C. Oosting, S.F. Rácz, E. Br J Dermatol Correspondence John Wiley and Sons Inc. 2021-11-02 2022-02 /pmc/articles/PMC9298061/ /pubmed/34597438 http://dx.doi.org/10.1111/bjd.20774 Text en © 2021 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Correspondence Leus, A.J.G. Horváth, B. Terra, J.B. Diercks, G.F.H. Plaat, B.E.C. Oosting, S.F. Rácz, E. Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck |
| title | Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck |
| title_full | Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck |
| title_fullStr | Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck |
| title_full_unstemmed | Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck |
| title_short | Eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck |
| title_sort | eligibility criteria for programmed death receptor 1 inhibitors vs. real‐world advice: a retrospective analysis of 69 patients with advanced cutaneous squamous cell carcinoma of the head and neck |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298061/ https://www.ncbi.nlm.nih.gov/pubmed/34597438 http://dx.doi.org/10.1111/bjd.20774 |
| work_keys_str_mv | AT leusajg eligibilitycriteriaforprogrammeddeathreceptor1inhibitorsvsrealworldadvicearetrospectiveanalysisof69patientswithadvancedcutaneoussquamouscellcarcinomaoftheheadandneck AT horvathb eligibilitycriteriaforprogrammeddeathreceptor1inhibitorsvsrealworldadvicearetrospectiveanalysisof69patientswithadvancedcutaneoussquamouscellcarcinomaoftheheadandneck AT terrajb eligibilitycriteriaforprogrammeddeathreceptor1inhibitorsvsrealworldadvicearetrospectiveanalysisof69patientswithadvancedcutaneoussquamouscellcarcinomaoftheheadandneck AT diercksgfh eligibilitycriteriaforprogrammeddeathreceptor1inhibitorsvsrealworldadvicearetrospectiveanalysisof69patientswithadvancedcutaneoussquamouscellcarcinomaoftheheadandneck AT plaatbec eligibilitycriteriaforprogrammeddeathreceptor1inhibitorsvsrealworldadvicearetrospectiveanalysisof69patientswithadvancedcutaneoussquamouscellcarcinomaoftheheadandneck AT oostingsf eligibilitycriteriaforprogrammeddeathreceptor1inhibitorsvsrealworldadvicearetrospectiveanalysisof69patientswithadvancedcutaneoussquamouscellcarcinomaoftheheadandneck AT racze eligibilitycriteriaforprogrammeddeathreceptor1inhibitorsvsrealworldadvicearetrospectiveanalysisof69patientswithadvancedcutaneoussquamouscellcarcinomaoftheheadandneck |